Comorbid substance use and age at onset of schizophrenia.
about
Substance use in clinical high risk for psychosis: a review of the literatureAnimal models of gene-environment interaction in schizophrenia: A dimensional perspective.Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.Cannabis use disorders in schizophrenia: effects on cognition and symptomsA retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development.Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults.BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA.The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosisIncreasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophreniaOlanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.Screening for substance use disorders in first-episode psychosis: implications for readmission.Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population.The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.Responses to Tobacco Smoking-Related Health Messages in Young People With Recent-Onset SchizophreniaAssociation between age at onset of psychosis and age at onset of cannabis use in non-affective psychosisGender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcomeAn fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches.Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis.Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.What are the policy implications of the evidence on cannabis and psychosis?Drug and alcohol misuse in first episode psychosis: An observational study.Epidemiology of schizophrenia: review of findings and mythsSex difference in age of onset of schizophrenia: findings from a community-based study in India.Kraepelin's dichotomy is true: contrasting brain dysfunction at the extremes of human growth and maturation. Excitability, the fundamental property of nervous tissue, is affected.Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.Substance misuse and early psychosis.Sex differences in the course of schizophrenia across diverse regions of the world.Infantile autism: a chronic psychosis since infancy due to synaptic pruning of the supplementary motor area.Substance use and abuse in first-episode psychosis: prevalence before and after early interventionCannabis use and cognition in schizophrenia.Impact of substance use disorder on presentation and short-term course of schizophrenia.Beyond the first episode: candidate factors for a risk prediction model of schizophrenia.Cannabis and schizophrenia spectrum disorders: a review of clinical studies.A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications.Do former substance users with psychosis differ in their symptoms or function from non-substance users? A systematic meta-analysis.
P2860
Q26859349-6D4348FB-E374-4E24-93D2-121CDB005FB3Q30367009-8CE88A10-CCDE-4965-AF0F-4D1849D8BC45Q33976751-E9FF23F7-F6CF-4028-957F-1C66BBEDDE88Q33985743-0935CA65-2E49-4956-9F1E-8E984E48697AQ34020082-01C5C2AB-7120-48A1-92C4-5D1F15B946E6Q34524036-F5D9FEAD-8E53-4D7E-B29F-8A32920AD637Q34530176-260F7645-9D76-4B5A-8FE6-D8C7BF30F0CEQ34531537-1F80DAE1-2D54-4CF2-8AA2-3093B1CB49C2Q34612418-6E698CE8-C3AC-4978-9789-A64444C619B6Q34644737-D0E9265E-7F14-4913-A88B-020849E529C4Q35096017-D9C1371E-39A0-4A1D-8D61-1EAFB4215F9FQ35136787-A7D6045E-B7BA-4934-9DA3-BDD46FE0AAE2Q35323897-F19F18B4-274E-4FC1-8428-75FA42B5C5CAQ36092716-9CA87B7E-FE08-43A6-A5D4-DC7EE295FA9AQ36121507-FC8DDBE2-FBBD-499F-AEF1-A6E24EB376CDQ36148551-E4180AB3-AE47-46AC-8469-E283102FE2F2Q36154276-A73B93CA-8EF6-4B99-B234-F8C02960957DQ36168604-ACB34BB5-D4C4-4F97-89D3-FA74D03B61FFQ36281966-56398066-E097-4FD3-90D7-E1EE8A4DC63AQ36354947-A12B2D17-C103-48C2-8CC1-8B4B51274512Q36364218-C79026DE-AD80-4EC3-8E93-164A2A1DC764Q36577094-A48C02E0-01F8-442A-836B-CF7936B72CE5Q36591245-59355FA4-7B24-43CB-A9AD-8159E41E281BQ36606248-48D738FB-8F75-494F-AEE0-11CEA0479D5EQ36842165-9245321E-C7E8-4C36-B160-C81772C09527Q36919282-E938FE97-627E-4E49-AA72-5256B94F8093Q36919958-E9C5A7AD-90E9-4EAF-86C5-0D125F192E5BQ36948432-31EFCAD7-5543-487E-91E2-9551136EC279Q36959030-FAB6A820-8532-4A69-A5E8-DF6084AA3EBBQ37057539-C0896307-F2C2-47C5-A6F9-BE5FC6F88202Q37419167-167C63DA-EA8B-40A4-B696-ABB54B63BC5FQ37423268-3C4A62A1-E42B-424E-8BD6-D79F454736AAQ37425103-F274640B-5C2E-43E4-800E-B8AA72E4979BQ37427095-2EFD8AC5-49BC-4684-AB1E-7BE585632FC7Q37643444-F18DDBD2-A356-4E30-8601-481CACBF3B0FQ37719233-60B2A5DF-DA89-4EDC-94C9-2AC879C7B379Q37760933-47141767-4C91-4C93-91D6-FBF7AEB35300Q37936795-16211AD3-36DE-4F70-9357-51111E092FD7Q37998841-71365424-1718-4685-8570-909D2A2747E2Q38076103-F94B2C5C-DD19-4626-B5C8-1A275AA9CD9E
P2860
Comorbid substance use and age at onset of schizophrenia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Comorbid substance use and age at onset of schizophrenia.
@en
Comorbid substance use and age at onset of schizophrenia.
@nl
type
label
Comorbid substance use and age at onset of schizophrenia.
@en
Comorbid substance use and age at onset of schizophrenia.
@nl
prefLabel
Comorbid substance use and age at onset of schizophrenia.
@en
Comorbid substance use and age at onset of schizophrenia.
@nl
P2093
P1476
Comorbid substance use and age at onset of schizophrenia.
@en
P2093
Eileen M Joyce
Hilary C Watt
Sam B Hutton
Stanley H Mutsatsa
Thomas R E Barnes
P304
P356
10.1192/BJP.BP.104.007237
P407
P577
2006-03-01T00:00:00Z